Lin Dang

1.3k total citations · 1 hit paper
34 papers, 786 citations indexed

About

Lin Dang is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Lin Dang has authored 34 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 11 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Lin Dang's work include Psoriasis: Treatment and Pathogenesis (9 papers), Dermatology and Skin Diseases (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Lin Dang is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (9 papers), Dermatology and Skin Diseases (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Lin Dang collaborates with scholars based in China, United States and Hong Kong. Lin Dang's co-authors include Tangfeng Lv, Junliang Zhang, Junwei Gu, Kuan Zhang, Xuan Wang, Chunchun Zhi, Qin Shen, Xi Chen, Wenjun Liang and Yong Song and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.

In The Last Decade

Lin Dang

31 papers receiving 780 citations

Hit Papers

High intrinsic thermal conductivity and low dielectric co... 2025 2026 2025 5 10 15 20

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Dang China 14 312 289 172 168 144 34 786
Jiangtao Wang China 15 188 0.6× 201 0.7× 92 0.5× 106 0.6× 147 1.0× 66 831
Jiabei He China 8 341 1.1× 319 1.1× 153 0.9× 142 0.8× 113 0.8× 13 843
Yuchen Guo China 15 390 1.3× 211 0.7× 84 0.5× 249 1.5× 142 1.0× 39 793
Luyan Shen China 21 616 2.0× 259 0.9× 106 0.6× 261 1.6× 122 0.8× 70 1.2k
Kaiwen Li China 19 330 1.1× 178 0.6× 117 0.7× 150 0.9× 279 1.9× 88 1.1k
Liuling Xiao United States 15 483 1.5× 271 0.9× 347 2.0× 470 2.8× 365 2.5× 25 1.6k
Xiangyu Zeng China 18 365 1.2× 196 0.7× 90 0.5× 133 0.8× 179 1.2× 63 955
Zongcheng Li China 18 482 1.5× 90 0.3× 245 1.4× 188 1.1× 61 0.4× 43 1.1k
Fangming Gu China 19 332 1.1× 277 1.0× 182 1.1× 238 1.4× 82 0.6× 44 1.3k
Junyi Hu China 16 499 1.6× 330 1.1× 242 1.4× 235 1.4× 239 1.7× 43 1.0k

Countries citing papers authored by Lin Dang

Since Specialization
Citations

This map shows the geographic impact of Lin Dang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Dang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Dang more than expected).

Fields of papers citing papers by Lin Dang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Dang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Dang. The network helps show where Lin Dang may publish in the future.

Co-authorship network of co-authors of Lin Dang

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Dang. A scholar is included among the top collaborators of Lin Dang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Dang. Lin Dang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, You-Sheng, Li Deng, Fuxi Wang, et al.. (2025). Epidemiological Profile of Psoriasis and Linked Comorbidities in Chinese Population at Shenzhen: A Cross‐Sectional Study. Health Science Reports. 8(9). e71159–e71159. 1 indexed citations
2.
Li, Yunhui, et al.. (2024). ACOT7 positively regulated by CREB1 promotes the progression of cutaneous melanoma. Acta Histochemica. 126(5-7). 152186–152186.
3.
Wang, Huiwei, Jialiang Shi, Xiaojing Kang, et al.. (2024). A large-scale retrospective study in China explores risk factors for disease severity in plaque psoriasis. Scientific Reports. 14(1). 25749–25749.
5.
Sun, Zhaojun, et al.. (2024). LncRNA RP11-818O24.3 promotes hair-follicle recovery via FGF2-PI3K/Akt signal pathway. Cytotechnology. 76(4). 425–439. 2 indexed citations
7.
Zhang, Junliang, et al.. (2023). Effect of the Structure of Epoxy Monomers and Curing Agents: Toward Making Intrinsically Highly Thermally Conductive and Low-Dielectric Epoxy Resins. SHILAP Revista de lepidopterología. 3(12). 3424–3435. 96 indexed citations
8.
Zhang, Kuan, Lin Dang, & Junliang Zhang. (2023). Fast Degradable and Thermally Conductive Silicone Rubber Vitrimer with Low Dielectric and UV‐Shielding Properties. Macromolecular Chemistry and Physics. 224(24). 4 indexed citations
9.
Jiang, Yuxiong, Ying Li, Dawei Huang, et al.. (2023). Quality of Life Benefit and Clinical Predictors of Complete Skin Clearance in Psoriasis: A Multicenter, Prospective, Real-World Study. Dermatology. 239(5). 802–810. 7 indexed citations
10.
Hao, Siyu, et al.. (2022). ANRIL polymorphisms in psoriasis vulgaris patients in northern China. European Journal of Dermatology. 32(2). 259–268. 5 indexed citations
11.
Zhao, Feng, Haiying Zhou, Lin Dang, et al.. (2022). A tumor-associated autoantibody panel for the detection of non-small cell lung cancer. Frontiers in Oncology. 12. 1056572–1056572. 5 indexed citations
12.
Zhou, Li, Yanling Lv, Zimu Wang, et al.. (2021). Association of MUC19 Mutation With Clinical Benefits of Anti-PD-1 Inhibitors in Non-small Cell Lung Cancer. Frontiers in Oncology. 11. 596542–596542. 8 indexed citations
13.
Li, Chuling, Chunchun Zhi, Wenjun Liang, et al.. (2019). Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients. Journal of Translational Medicine. 17(1). 355–355. 187 indexed citations
14.
Xu, Yangyang, Bing Wan, Xi Chen, et al.. (2019). The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials. Translational Lung Cancer Research. 8(4). 413–428. 118 indexed citations
15.
Li, Huijuan, Yangyang Xu, Bing Wan, et al.. (2019). The clinicopathological and prognostic significance of PD-L1 expression assessed by immunohistochemistry in lung cancer: a meta-analysis of 50 studies with 11,383 patients. Translational Lung Cancer Research. 8(4). 429–449. 51 indexed citations
16.
Shen, Kaikai, Yuqing Wei, Xiaojun Chen, et al.. (2018). Effectiveness and safety of PD-1/PD-L1 or CTLA4 inhibitors combined with chemotherapy as a first-line treatment for lung cancer: A meta-analysis. Journal of Thoracic Disease. 10(12). 6636–6652. 34 indexed citations
17.
Gao, Xin, M Kellis, Chunyan Qian, et al.. (2016). MiR-21 functions oppositely in proliferation and differentiation of neural stem/precursor cells via regulating AKT and GSK-3β. Cellular and Molecular Biology. 62(12). 144–144. 15 indexed citations
18.
Dang, Lin, et al.. (2015). Low-dose UVB irradiation prevents MMP2-induced skin hyperplasia by inhibiting inflammation and ROS. Oncology Reports. 34(3). 1478–1486. 16 indexed citations
19.
Dang, Lin, et al.. (2015). Role of the complement anaphylatoxin C5a-receptor pathway in atopic dermatitis in mice. Molecular Medicine Reports. 11(6). 4183–4189. 8 indexed citations
20.
Qin, Shucun, Lin Dang, Guohua Song, et al.. (2014). Psoriasis decreases the anti-oxidation and anti-inflammation properties of high-density lipoprotein. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1841(12). 1709–1715. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026